Gene: PLBD2
Official Full Name: phospholipase B domain containing 2provided by HGNC
Gene Summary: Predicted to enable phospholipase activity. Predicted to be involved in phospholipid catabolic process. Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21453 | PLBD2 Knockout cell line (HeLa) | Human | PLBD2 | 1:3~1:6 | Negative | Online Inquiry |
KO21454 | PLBD2 Knockout cell line (HCT 116) | Human | PLBD2 | 1:2~1:4 | Negative | Online Inquiry |
KO21455 | PLBD2 Knockout cell line (HEK293) | Human | PLBD2 | 1:3~1:6 | Negative | Online Inquiry |
KO21456 | PLBD2 Knockout cell line (A549) | Human | PLBD2 | 1:3~1:4 | Negative | Online Inquiry |
PLBD2 Gene Knockout Cell Lines are genetically engineered cell lines specifically designed to lack the expression of the PLBD2 gene, providing a valuable tool for researchers studying the functional roles of this gene in various biological processes. By employing CRISPR-Cas9 or other knockout methodologies, these cell lines allow for precise evaluation of gene function, offering insights into cell signaling, metabolic pathways, and disease mechanisms that are influenced by PLBD2.
The primary mechanism behind the utility of PLBD2 Gene Knockout Cell Lines stems from their ability to facilitate the investigation of gene-gene interactions and cellular responses in a controlled environment. Without the PLBD2 gene, researchers can study the compensatory mechanisms that may arise and assess the impact of its absence on cellular phenotypes such as proliferation, differentiation, and response to treatments. This enables a comprehensive understanding of how PLBD2 may contribute to various physiological and pathological conditions, thus driving forward our grasp of cellular dynamics.
Scientifically, the importance of PLBD2 Gene Knockout Cell Lines lies in their applicability in both exploratory research and translational studies. These cell lines can be utilized in drug discovery, gene therapy development, and the study of complex diseases, including cancer and metabolic disorders, where PLBD2 may play a pivotal role. Moreover, they provide a critical framework for functional assays, high-throughput screening, and validation of therapeutic targets.
Unlike traditional methods that may rely on transient knockdown techniques, our PLBD2 Gene Knockout Cell Lines offer stable and permanent gene disruption, ensuring consistent and reproducible results. This stability increases the reliability of experimental outcomes and minimizes variability associated with temporary alterations, thus making them a superior choice for long-term studies.
For researchers, clinicians, and biotech professionals, the PLBD2 Gene Knockout Cell Lines present a unique opportunity to gain in-depth knowledge of gene functions that could lead to innovative therapeutic strategies and breakthroughs in understanding human diseases. Our company prides itself on its commitment to providing high-quality, cutting-edge biological products backed by a robust database of scientific expertise and technical support, making us a trusted partner in advancing research initiatives.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.